Dual Function of Nitric Oxide in Carcinogenesis, Reappraisal
Journal:
Current Drug Metabolism
Volume:
12
Page:
891-899
Author(s):
Ayse Basak Engin
The HOX Genes Network in Uro-Genital Cancers: Mechanisms and Potential Therapeutic Implications
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4872-4884
Author(s):
M. Cantile, R. Franco, G. Schiavo, A. Procino, L. Cindolo, G. Botti and C. Cillo
Anticancer Metallotherapeutics in Preclinical Development
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4738-4752
Author(s):
G. N. Kaluderovic and R. Paschke
Polyphenol Supplementation as a Complementary Medicinal Approach to Treating Inflammatory Bowel Disease
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4851-4865
Author(s):
F. Biasi, M. Astegiano, M. Maina, G. Leonarduzzi and G. Poli
Xanthones from Mangosteen Extracts as Natural Chemopreventive Agents: Potential Anticancer Drugs
Journal:
Current Molecular Medicine
Volume:
11
Page:
666-677
Author(s):
T. Shan, Q. Ma, K. Guo, J. Liu, W. Li, F. Wang and E. Wu
Rational Targeting of the Urokinase Receptor (uPAR): Development of Antagonists and Non-Invasive Imaging Probes
Journal:
Current Drug Targets
Volume:
12
Page:
1711-1728
Author(s):
M. C. Kriegbaum, M. Persson, L. Haldager, W. Alpizar-Alpizar, B. Jacobsen, H. Gardsvoll, A. Kjaer and M. Ploug
Structural Basis for Therapeutic Intervention of uPA/uPAR System
Journal:
Current Drug Targets
Volume:
12
Page:
1729-1743
Author(s):
Jacky Chi Ki Ngo, Longguang Jiang, Zhonghui Lin, Cai Yuan, Zhuo Chen, Xu Zhang, Haiyang Yu, Jundong Wang, Lin Lin and Mingdong Huang
uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy
Journal:
Current Drug Targets
Volume:
12
Page:
1744-1760
Author(s):
Ida K. Lund, Martin Illemann, Tine Thurison, Ib J. Christensen and Gunilla Hoyer-Hansen
New Prognostic Markers and Potential Therapeutic Targets in Human Testicular Germ Cell Tumors
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
5033-5040
Author(s):
P. Chieffi
Anti-VEGF and Anti-EGFR Monoclonal Antibodies in the First-line Therapy for Metastatic Colorectal Cancer - A Meta-Analysis
Journal:
Current Cancer Therapy Reviews
Volume:
7
Page:
282-289
Author(s):
Zheng Zhou, William V. Walsh, Venu G. Bathini and Bilal Piperdi